Cancer News and Research

Latest Cancer News and Research

RetroNectin reagent now available for gene therapy clinical research

In an effort to aid progress in gene therapy clinical research, representatives of Clontech laboratories, Inc. and its parent company Takara Bio Inc. announce the availability of clinical grade RetroNectin reagent for direct supply to biomedical researchers.

17 Jun 2013

CEO Roundtable on Cancer recognizes UMB Financial with CEO Cancer Gold Standard

UMB Financial Corporation, a financial services holding company headquartered in Kansas City, MO, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior. The CEO Roundtable on Cancer recently accredited UMB Financial with the CEO Cancer Gold Standard.

17 Jun 2013

First Edition: June 17, 2013

Today's headlines include reports about how states are tackling the implementation of specific provisions of the health law.

17 Jun 2013

Study: British South Asians more likely to be severely depressed following cancer diagnosis

The first study of its kind to investigate depression following cancer diagnosis among British white people and South Asians in the UK has discovered that South Asians are five times more likely to be severely depressed.

17 Jun 2013

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Genmab A/S and ADC Therapeutics Sarl, announced today an agreement to develop a new antibody-drug conjugate product combining Genmab's HuMax-TAC antibody and ADC Therapeutics' PBD-based warhead and linker technology.

17 Jun 2013

Minority children with autism less likely to have received subspecialty care or procedures, study finds

A study from investigators at MassGeneral Hospital for Children found that African-American or Hispanic children diagnosed with autism were significantly less likely than white children to have received subspecialty care or procedures related to conditions that often accompany autism spectrum disorders.

17 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013

Mount Sinai researchers present several new studies at ENDO 2013

Researchers from the Icahn School of Medicine at Mount Sinai will present several new studies at ENDO 2013, The Endocrine Society's Annual Meeting & Expo from June 15-18 in San Francisco.

17 Jun 2013

Researchers identify genetic mutation responsible for MDP Syndrome

National Paracycling Champion Tom Staniford has an extremely rare condition which, until now, has puzzled his doctors. He is unable to store fat under his skin - yet has type 2 diabetes - and suffered hearing loss as a child. Now, thanks to advances in genome sequencing, an international research team led by the University of Exeter Medical School has identified Tom's condition and pinpointed the single genetic mutation that causes it.

17 Jun 2013

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.

17 Jun 2013

Eli Lilly, BIPI support ADA's call for independent review of incretin-based therapies

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company support the American Diabetes Association call for an independent review of the safety data of incretin-based therapies.

17 Jun 2013

Study shows how cancer cells interact with healthy cells to migrate around the body during metastasis

A mechanism that cells use to group together and move around the body - called 'chase and run' - has been described for the first time by scientists at UCL.

17 Jun 2013

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.

17 Jun 2013

$Study: Older patients will make positive lifestyle changes to avoid risk of fractures$

Study: Older patients will make positive lifestyle changes to avoid risk of fractures

Older patients who know they are at risk of fractures will make positive lifestyle changes to avoid them, such as exercising, wearing proper footwear and taking supplements, a new study has found.

16 Jun 2013

New infographic provides healthy grilling tips to avoid cancer-causing agents

Adults can avoid cancer-causing agents when they barbecue by using the healthy grilling tips in the new infographic, "How to fill a healthy barbecue plate," created by experts at The University of Texas MD Anderson Cancer Center.

16 Jun 2013

Dr. Todd Darmody honored with 2012 Compassionate Doctor Certification

Patients' Choice has announced that Dr. Todd Darmody, MD was one of a select few physicians honored with the prestigious 2012 Compassionate Doctor Certification.

15 Jun 2013

Google to feature health-centered Google+ Hangouts for International Men's Health Month

Google, in partnership with WireBuzz.com and Prevention.com, will feature a series of health-centered Google+ Hangouts for International Men's Health Month. The live discussions will build awareness around men's health issues including diet and exercise, cancer, sexual health and more.

15 Jun 2013

Dana Sellers wins 2013 Ernst & Young Entrepreneur of the Year for Healthcare in the Gulf Coast Area

Encore Health Resources, a leading health-information technology services company, announced today that its founding CEO, Dana Sellers, has been named the 2013 Ernst & Young Entrepreneur of the Year for Healthcare in the Gulf Coast Area.

15 Jun 2013

Pathway Genomics to provide genetic testing for BRCA gene linked to breast, ovarian cancers

Pathway Genomics led the evening news Friday with an announcement that it could begin offering affordable access to genetic testing for the BRCA gene linked to breast and ovarian cancers in the wake of a Supreme Court ruling that eliminated another company's monopoly on the test.

15 Jun 2013

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced results from PALACE 3, the Company's third phase III study in psoriatic arthritis (PsA), at EULAR, the European Congress of Rheumatology annual meeting in Madrid, Spain.

15 Jun 2013

Cancer News and Research

Latest Cancer News and Research

RetroNectin reagent now available for gene therapy clinical research

CEO Roundtable on Cancer recognizes UMB Financial with CEO Cancer Gold Standard

First Edition: June 17, 2013

Study: British South Asians more likely to be severely depressed following cancer diagnosis

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Minority children with autism less likely to have received subspecialty care or procedures, study finds

European Commission amends marketing authorisation for Celgene's REVLIMID

Mount Sinai researchers present several new studies at ENDO 2013

Researchers identify genetic mutation responsible for MDP Syndrome

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Eli Lilly, BIPI support ADA's call for independent review of incretin-based therapies

Study shows how cancer cells interact with healthy cells to migrate around the body during metastasis

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Study: Older patients will make positive lifestyle changes to avoid risk of fractures

New infographic provides healthy grilling tips to avoid cancer-causing agents

Dr. Todd Darmody honored with 2012 Compassionate Doctor Certification

Google to feature health-centered Google+ Hangouts for International Men's Health Month

Dana Sellers wins 2013 Ernst & Young Entrepreneur of the Year for Healthcare in the Gulf Coast Area

Pathway Genomics to provide genetic testing for BRCA gene linked to breast, ovarian cancers

Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in